Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The revised elastic field of an edge dislocation.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same author

Sodium fluoride (Na<sup>18</sup>F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors.

ESMO open·2023

Same author

Approach to initial management of canine generalised epileptic seizures in primary-care veterinary practices in the United Kingdom.

The Journal of small animal practice·2022

Same author

DNA dosimeter measurements of beam profile using a novel simultaneous processing technique.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2020

Same author

Optimizing the response, precision, and cost of a DNA double-strand break dosimeter.

Physics in medicine and biology·2019

Same author

Early feeding after free flap reconstruction for oral cancer.

The British journal of oral & maxillofacial surgery·2015

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Mifamurtide in osteosarcoma--a practical review.

P M Anderson¹, M Tomaras, K McConnell

¹University of Texas, MD Anderson Cancer Center, Dept. of Pediatrics, Houston, Texas 77030-4009, USA. pmanders@mdanderson.org

Drugs of Today (Barcelona, Spain : 1998)

|June 3, 2010

Summary

Mifamurtide, a liposomal muramyl tripeptide phosphatidyl ethanolamine (L-MTP-PE), activates immune cells to treat osteosarcoma lung metastases. It improves survival rates by 8-13% when combined with chemotherapy, with manageable side effects.

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Related Experiment Videos

Last Updated: Jun 12, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Area of Science:

Immunology
Pharmacology
Oncology

Background:

Mifamurtide (L-MTP-PE) is approved in Europe for osteosarcoma treatment.
It utilizes liposomes with synthetic phospholipids to activate macrophages.
The drug targets immune cells, not directly cytotoxic to tumor cells.

Purpose of the Study:

To evaluate the efficacy and safety of mifamurtide in osteosarcoma treatment.
To understand the mechanism of action of mifamurtide in activating immune responses.
To present an algorithm for managing mifamurtide's short-term toxicities.

Main Methods:

Mifamurtide was administered with chemotherapy to osteosarcoma patients.
Immune cell activation and survival rates were monitored.
Pre- and postmedication protocols, including ibuprofen, were used to manage side effects.

Main Results:

Mifamurtide improved 5- and 6-year overall survival by 13% and 8% respectively in metastatic and non-metastatic patients.
Short-term toxicities like fever and flu-like symptoms were reduced with premedication.
No long-term side effects have been reported to date.

Conclusions:

Mifamurtide demonstrates significant survival benefits in osteosarcoma patients.
Its mechanism involves immune activation rather than direct cytotoxicity.
Mifamurtide represents a successful collaboration in pediatric cancer treatment.